Home > Resources > Whitepapers > Perspectives and Good Practices for AI and Continuously Learning Systems in Healthcare

Perspectives and Good Practices for AI and Continuously Learning Systems in Healthcare

August 20, 2018

In the past few years, there has been a significant increase in the amount of information in healthcare, and this trend is accelerating. In addition to traditional data, such as those collected by in-vitro laboratory tests, imaging devices, physiological tests, and electronic health records, there are additional systems collecting, integrating and analyzing information and more ways for us to use it in our everyday lives. Wearable technologies are just the tip of the information iceberg as the Internet of Things (IoT) will continually monitor our lives and have real potential to give us insights into how to improve healthcare.

Spotlight

Bioarray

Bioarray is a technology-based firm, specialized in genetic analysis through cutting-edge technologies in Molecular Biology, primarily DNA microarrays/CGH and NGS, applied both to clinical and research purposes.We continuously develop our service portfolio also being flexible with client’s requirements, including customized gene panels or tailored genomic research projects requiring unparalleled bioinformatics, gene expression microarrays, RNA-seq, miRNA, methylation analysis, etc.

OTHER WHITEPAPERS

Improve Your Gene-Editing Success With CRISPR-SNIPER Technology

whitePaper | February 15, 2023

The discovery of both CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated proteins, the Cas nucleases, has revolutionized the field of gene-editing.

HIGH THROUGHPUT AAV VIRAL TITERING USING NANOPLATE-BASED DIGITAL PCR

whitePaper | December 22, 2022

Determining the physical titer of viral vectors has typically been accomplished using digital droplet PCR (ddPCR). Droplet-based methods, however, are challenged by matrix effects and long analysis times (up to 7 hours).

Covid-19 Vaccine Distribution System

whitePaper | April 14, 2021

Delivering Covid-19 vaccines to 7.8 billion people is a daunting challenge that will stretch supply chains past their limits. Even if all the needed doses were ready today, vaccine manufacturers still must find solutions to deliver multiple doses of those vaccines to most people on the planet. To read more, please download this free white paper.

Best Practices for RIM Business Process Automation

whitePaper | December 15, 2022

Regulatory teams at life science companies are finding that effective regulatory information management (RIM) has become critical to their operations.

Cell and Gene Therapy Clinical Trials

whitePaper | November 8, 2022

Using experienced-based best practices and documented tools, ICON has conducted over 63 CGT trials across multiple therapeutic areas from haematology-oncology torare and orphan diseases.

Mainstreaming Cell & Gene Therapies

whitePaper | October 27, 2022

The cell and gene therapy (CGT) market is rapidly transitioning from ultra-niche cutting-edge science to approved and available therapies that can address previously intractable and often devastating diseases.